Vinorelbine Plus Cisplatin Combination Chemotherapy in Advanced Non-small-cell Lung Cancer

Objective To evaluate the efficacy and toxicity of vinorelbine(NVB) plus cisplatin(NP regimen) combination chemotherapy in advanced non small cell lung cancer(NSCLC). Methods A total of 160 patients with advanced non small cell lung cancer were treated by NP regimen: NVB 25 mg/m 2,d 1,8 ; cisplatin 80 mg/m 2,d 1. All of them had stage Ⅲ b～Ⅳ disease, They were primary treatment. Results The overall response rate (RR) was 55.6%, The median response time 6.2 months. The median survival tim...